Metware Biotechnology
PrivateLast Round
Series B
Apr 2, 2024
Total Funding Raised
$15.49M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Metware Biotechnology operates in Healthcare & Life Sciences and is based in Woburn, Massachusetts. Its latest recorded funding round was a Series B round in April 2024.
Metware Biotechnology is a biotechnology company that provides multi-omics services, including proteomics, metabolomics, and lipidomics, for academic research, clinical studies, and pharmaceutical development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metware Biotechnology Comparables
Compare Metware Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Panome Bio | 87% | |
| Dalton Bioanalytics | 85% | |
| Creative Proteomics | 85% |
For institutional investors. Book with your work email.
Metware Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 2, 2024 | ||||
| Series A | Sep 24, 2021 | ||||
| Angel | Sep 22, 2017 |
For institutional investors. Book with your work email.
Metware Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wuhan Institute of Biotechnology | Angel |
| Tianjin Haida Venture Capital Management | Series B |
| HongShan Capital Group (HSG) | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
Grew 21% QoQ, from 19 to 23 employees.
- Jul 24, 2026
Grew 19% QoQ, from 16 to 19 employees.
For institutional investors. Book with your work email.
Metware Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Metware Biotechnology's valuation, stock price, and market status.
Is Metware Biotechnology a public or private company?
Metware Biotechnology is a private company.
What is the current stock price of Metware Biotechnology?
Metware Biotechnology is a private company, so its shares have no public market price. Caplight tracks Metware Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Metware Biotechnology worth (valuation)?
Valuation information for Metware Biotechnology is not publicly available.
Can I buy Metware Biotechnology stock?
Metware Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Metware Biotechnology's last funding round?
Metware Biotechnology's most recent funding round was Series B on April 2, 2024.
Who are the main investors in Metware Biotechnology?
Key investors in Metware Biotechnology include Tianjin Haida Venture Capital Management, HongShan Capital Group (HSG).
Will Metware Biotechnology IPO soon?
No public IPO plans have been announced for Metware Biotechnology.
How can I track Metware Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Metware Biotechnology's shares on secondary markets.